CHEMED CORP

CHE

Explore Our Financial Data > Companies > CHEMED CORP

Identification

Click on a field for details on how to access that data via Web API, Excel, or CSV Download.

Ticker	CHE
CIK	0000019584
SIC	8082
Sector	Services
Industry Category	Healthcare
Industry Group	Services – Health

Contact

Address	SUITE 2600, 255 E FIFTH ST, CINCINNATI, OH, 45202
Website	chemed.com
Phone	(513)762-6690
CEO	Kevin J. McNamara
Employees	14,200

Access This Data

Our team will help you customize a package that meets the needs of your business.

Request a Consultation

Standardized Financials

docs

Intrinio provides professional-grade historical financial data. This data is standardized, cleansed and verified to ensure the highest quality data sourced directly from the XBRL financial statements. The primary purpose of standardized financials are to facilitate comparability across a single company’s fundamentals and across all companies fundamentals.

For example, it is possible to compare total revenues between two companies as of a certain point in time, or within a single company across multiple time periods. This is not possible using the as reported financial statements because of the inherent complexity of reporting standards.

Below is a preview of several data points from each financial statement, as well as a sample of our many calculated metrics:

Income Statement

Revenue	$2.53 billion
Pre-Tax Income	$355.78 million
Net Income	$265.24 million
Net Income to Common	$265.24 million
EPS	$18.34

View All

Balance Sheet

Cash	$74.52 million
Assets	$1.54 billion
Liabilities	$558.78 million
Common Equity	$979.40 million
Liabilities & Equity	$1.54 billion

View All

Cash Flow Statement

Net Income	$265.24 million
Cash From Operating Activities	$388.27 million
Cash From Investing Activities	$-59.34 million
Cash From Financing Activities	$-432.77 million
Change in Cash	$-103.84 million

View All

Calculations

NOPAT	$252.17 million
EBITDA	$422.69 million
Price to Earnings	$19.75
Price to Book	$5.35
ROE	25.28%

View All

Latest News

docs

Intrinio provides up-to-date news articles on every US company from various sources. Here are several examples:

Chemed To Report First Quarter 2026 Earnings April 23, Related Conference Call To Be Held On April 24

CINCINNATI, April 01, 2026 (GLOBE NEWSWIRE) -- Chemed Corporation (NYSE: CHE) today announced that it will release financial results for the first quarter ended March 31, 2026, on Thursday, April 23, 2026, following the close of trading on the New York Stock Exchange. Chemed will host a conference call and webcast at 10 a.m., ET, on Friday, April 24, 2026, to discuss the company's quarterly results and to provide an update on its business. Participants may access a live webcast of the conference

Article Link

Roto-Rooter Completes Acquisitions for Two Significant Territories

CINCINNATI, April 01, 2026 (GLOBE NEWSWIRE) -- On March 31, Roto-Rooter Services Company, a wholly owned subsidiary of Chemed Corporation ("Chemed") (NYSE: CHE) announced it has purchased the territory and assets of the franchises operating in San Francisco, California and Fort Worth, Texas in two separate transactions. The aggregated, combined purchase price of these transactions was approximately $20.6 million. Collectively, these Roto-Rooter locations serve a population of approximately 3.3 m

Article Link

1 Profitable Stock on Our Buy List and 2 We Ignore

Even if a company is profitable, it doesn’t always mean it’s a great investment. Some struggle to maintain growth, face looming threats, or fail to reinvest wisely, limiting their future potential.

Article Link

Why Is Chemed (CHE) Down 6.2% Since Last Earnings Report?

Chemed (CHE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Article Link

Chemed’s Weak Quarter And EPS Miss Prompt Fresh Risk Reassessment

Chemed, NYSE:CHE, reported a flat revenue performance year on year and missed its full year earnings per share guidance. The company also fell short of revenue expectations for the year, ranking as the weakest performer among its peer group. For investors watching NYSE:CHE, the weak full year showing comes on top of a challenging share price path. The stock closed at $371.95 and is down 20.6% over the past month, 12.2% year to date, and 39.0% over the past year, with a 28.7% decline over...

Article Link